Aytu Biopharma Balance Sheet (2011-2026) | AYTU

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	49.90M	40.31M	35.28M	27.61M	19.36M	23.81M	19.50M	19.18M	22.98M	19.96M	19.53M	19.76M	20.01M	20.11M	20.40M	18.17M	30.95M	32.63M	30.02M	26.71M
Short-term Investments (Quarter)	0.25M	0.25M
Cash & Current Investments (Quarter)	50.15M	40.56M	35.28M	27.61M	19.36M	23.81M	19.50M	19.18M	22.98M	19.96M	19.53M	19.76M	20.01M	20.11M	20.40M	18.17M	30.95M	32.63M	30.02M	26.71M
Receivables - Net (Quarter)	30.32M	21.63M	22.99M	27.61M	24.22M	27.92M	25.55M	34.00M	31.72M	29.88M	29.40M	29.93M	23.53M	23.16M	25.40M	35.83M	31.16M	33.23M	30.92M	24.49M
Receivables - Other (Quarter)	0.02M	0.01M
Receivables (Quarter)	30.35M	21.64M	22.99M	27.61M	24.22M	27.92M	25.55M	34.00M	31.72M	29.88M	29.40M	29.93M	23.53M	23.16M	25.40M	35.83M	31.16M	33.23M	30.92M	24.49M
Raw Materials (Quarter)	2.27M	2.64M	2.43M	1.80M	1.81M	2.11M	1.79M	2.22M	1.30M	1.97M	1.65M	1.85M	0.27M	0.72M	0.49M	0.54M	1.11M	1.37M	1.21M	1.37M
Work In Process (Quarter)	3.35M	3.01M	2.17M	2.22M	1.84M	2.37M	2.80M	2.82M	2.96M	3.29M	2.67M	5.02M	5.72M	3.36M	3.10M	2.06M	1.38M	0.86M	1.82M	2.05M
Finished Goods (Quarter)	10.72M	10.67M	11.96M	9.87M	7.20M	8.38M	8.36M	8.60M	7.74M	7.71M	8.67M	6.32M	6.15M	7.66M	7.49M	8.46M	8.94M	7.87M	5.63M	4.04M
Inventory (Quarter)	16.34M	16.31M	16.56M	13.89M	10.85M	12.87M	12.95M	13.64M	11.99M	12.97M	13.00M	13.19M	12.14M	11.74M	11.09M	11.06M	11.43M	10.10M	8.66M	7.46M
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	1.04M	1.20M	1.42M	0.89M	0.63M	9.02M	0.62M	1.18M	7.16M	7.04M	8.11M	1.00M	5.10M	5.73M	6.17M	7.46M	5.64M	5.15M	6.64M	8.66M
Current Assets (Quarter)	105.23M	89.04M	87.50M	77.95M	59.93M	74.42M	70.61M	78.47M	72.83M	70.60M	71.37M	71.13M	61.89M	60.74M	63.05M	72.51M	79.18M	81.11M	76.24M	67.33M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	5.14M	4.67M	4.29M	3.48M	3.02M	2.67M	2.34M	2.03M	1.81M	1.72M	1.13M	0.97M	0.69M	0.69M	0.52M	0.55M	0.53M	0.50M	0.48M	0.41M
Goodwill (Quarter)	65.80M	46.35M	46.35M	8.64M
Intangibles (Quarter)	85.46M	83.39M	94.22M	74.43M	70.63M	89.55M	64.98M	63.46M	78.58M	78.58M	55.71M	54.08M	71.47M	51.20M	49.96M	71.47M	55.40M	55.40M	43.58M	42.49M
Goodwill & Intangibles (Quarter)	151.27M	129.73M	140.57M	83.06M	70.63M	89.55M	64.98M	63.46M	78.58M	78.58M	55.71M	54.08M	71.47M	51.20M	49.96M	71.47M	55.40M	55.40M	43.58M	42.49M
Long-Term Deferred Tax (Quarter)									0.10M
Other Non-Current Assets (Quarter)	0.47M	0.47M	0.46M	0.77M	0.77M	0.83M	0.82M	0.89M	2.54M	0.77M	0.91M	0.89M	0.04M				1.20M	0.94M	0.74M	0.56M
Non-Current Assets (Quarter)	160.43M	138.69M	136.28M	90.88M	77.69M	75.58M	70.83M	68.75M	65.38M	62.29M	59.88M	57.73M	56.20M	55.09M	53.17M	51.69M	45.00M	43.88M	45.76M	44.36M
Assets (Quarter)	265.67M	227.73M	223.82M	168.83M	137.62M	150.00M	141.44M	147.22M	136.46M	132.89M	131.25M	128.86M	118.09M	115.83M	116.23M	124.20M	124.18M	124.99M	122.00M	111.69M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	19.25M	9.38M	15.60M	11.13M	10.99M	14.67M	10.58M	14.67M	13.48M	14.47M	10.47M	10.47M	10.31M	13.51M	11.70M	12.04M	10.60M	12.34M	14.26M	13.21M
Notes Payables (Quarter)					3.81M		7.43M	10.40M	1.56M	1.22M	1.03M	1.58M	2.40M	4.27M	4.01M
Payables (Quarter)	19.25M	9.38M	15.60M	11.13M	14.80M	14.67M	18.01M	25.08M	15.04M	15.68M	11.50M	12.06M	12.71M	17.78M	15.71M	12.04M	10.60M	12.34M	14.26M	13.21M
Accumulated Expenses (Quarter)	5.94M	54.38M	50.69M	53.47M	44.19M	41.43M	4.11M	49.59M	46.80M	5.37M	43.41M	44.09M	4.60M	33.72M	39.37M	41.73M	3.13M	3.95M	2.29M	34.27M
Other Accumulated Expenses (Quarter)	8.35M	3.19M	3.17M	3.54M	3.66M	8.09M	7.83M	7.45M	2.02M	8.99M	2.53M	1.87M	8.96M	2.83M	3.03M	1.85M	3.38M	0.22M	2.92M	2.20M
Short term Debt (Quarter)	7.93M	4.52M	1.21M	3.38M	3.81M	0.93M	0.09M	10.40M	1.56M	0.06M	1.03M	1.58M	1.86M	1.86M	1.86M	1.86M	1.86M	14.87M	1.86M	10.41M
Current Leases (Quarter)	0.94M	1.08M	1.17M	1.20M
Current Taxes (Quarter)
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	109.44M	98.00M	100.57M	80.36M	64.44M	73.20M	67.15M	85.42M	69.02M	65.46M	64.19M	83.69M	62.23M	61.25M	64.05M	70.71M	63.06M	65.99M	65.56M	59.97M
Non-Current Liabilities
Non-Current Debt (Quarter)	0.18M	0.15M	0.13M	14.17M	14.28M	13.56M	14.53M	11.39M	14.71M	14.84M	14.98M		10.88M	10.43M	9.98M	9.54M	10.89M	10.45M	10.00M	9.55M
Convertible Debt (Quarter)
Non-Current Deffered Revenue (Quarter)
Liabilities from Discontinued Operations (Quarter)													0.56M
Non-Current Deferred Tax Liability (Quarter)	0.20M	0.10M	0.10M		0.10M				0.10M
Operating Leases (Quarter)	2.62M	2.76M	2.72M	2.41M
Other Non-Current Liabilities (Quarter)	18.48M	0.32M	0.56M	5.58M	12.80M	9.33M	9.78M	7.92M	6.40M	8.11M	6.34M	8.61M	12.74M	4.92M	6.39M	4.94M	4.92M	20.42M	27.34M	2.18M
Total Non-Current Liabilities (Quarter)	109.62M	115.91M	117.73M	102.11M	80.52M	92.32M	85.84M	98.38M	28.09M	92.61M	34.21M	14.40M	28.15M	24.75M	21.41M	18.60M	42.15M	35.82M	42.24M	16.57M
Total Liabilities (Quarter)	128.10M	116.23M	118.29M	107.68M	93.31M	101.65M	95.62M	106.30M	97.11M	100.72M	98.40M	98.09M	90.38M	86.00M	85.46M	89.30M	105.21M	101.82M	107.80M	76.55M
Shareholder's Equity
Total Debt (Quarter)	8.11M	4.67M	1.33M	17.55M	18.09M	14.48M	14.62M	21.79M	16.28M	14.90M	16.00M	1.58M	12.73M	12.29M	11.84M	11.39M	12.75M	25.32M	11.86M	19.96M
Common Equity (Quarter)	137.57M	111.50M	105.54M	61.14M	44.31M	48.35M	45.82M	40.91M	39.36M	32.17M	32.85M	30.78M	27.72M	29.83M	30.77M	34.90M	18.97M	23.17M	14.20M	35.14M
Shareholder's Equity (Quarter)	137.57M	111.50M	105.54M	61.14M	44.31M	48.35M	45.82M	40.91M	39.36M	32.17M	32.85M	30.78M	27.72M	29.83M	30.77M	34.90M	18.97M	23.17M	14.20M	35.14M
Liabilities and Shareholders Equity (Quarter)	265.67M	227.73M	223.82M	168.83M	137.62M	150.00M	141.44M	147.22M	136.46M	132.89M	131.25M	128.86M	118.09M	115.83M	116.23M	124.20M	124.18M	124.99M	122.00M	111.69M
Retained Earnings (Quarter)	-178.30M	-206.15M	-217.70M	-270.77M	-287.08M	-287.80M	-294.50M	-301.70M	-304.13M	-312.25M	-312.50M	-315.36M	-319.97M	-318.50M	-317.71M	-313.72M	-333.54M	-331.57M	-342.15M	-347.77M
Preferred Shares (Quarter)
Treasury Shares (Quarter)	1.96M	2.11M	2.16M	2.14M	0.08M	4.00	0.04M	0.04M	0.00M	0.00M	0.04M	0.03M	0.00M	0.02M	565.00	0.03M	0.03M	4.00	4.00	0.22M

Research Tools

Aytu Biopharma Balance Sheet (2011-2026) | AYTU

Create an account

Sign In

Reset Password